From November we are expanding our team of doctors - more appointments coming soon.
11 Producers and 147 Entries: The Flower Range in Polish Pharmacies (October 2026)
Blog

11 Producers and 147 Entries: The Flower Range in Polish Pharmacies (October 2026)

How many producers supply flower to Polish pharmacies, how many formulations do they have, and how much do they differ in THC range? We collected public data from pharmacy pages, leaflets and producer websites. As of 19.10.2026: 11 producers, 39 formulations, 147 entries.

An entry is a strain at a given THC content, so the same strain appearing at two THC values counts twice. The text describes the market and does not recommend any product.

Producers in numbers

ProducerCountry (per overview)FormulationsEntriesTHC
S-LABPoland25918-22%
TilrayCanada21718-22%
Synoptis Pharmano data31618-25%
AuroraCanada8131-29%
Canopy GrowthCanada7118-30%
Four 20 PharmaGermany4920-27%
CosmaPoland, cultivation in Portugal3820-22%
CantourageGermany6625-27.9%
PhytoPur BioPoland1324%
SuprobionPoland1323%
Bliss Pharmano data2222-25%

The "Country" column gives what follows from the producers' product pages and websites. Where the sources are not unambiguous, we leave "no data".

What the numbers show

  • One producer accounts for 40% of entries. S-LAB has 59 of the 147 entries, although only two formulations. More on this notation in the article on how to read a product name.
  • Three countries, three models. Canada (Aurora, Canopy Growth, Tilray), Germany (Cantourage, Four 20 Pharma) and Poland (S-LAB, PhytoPur Bio, Suprobion and Cosma with cultivation in Portugal).
  • High THC predominates. Most formulations fall in the 18-30% range. The exceptions are three lines with low THC and higher CBD: Aurora THC 1%/CBD 12%, Aurora Deutschland THC 8%/CBD 8% and Canopy Growth THC 8%/CBD 7%.
  • Different approaches to descriptions. Cosma publishes product pages with a code and terpene profile on its website; Synoptis Pharma gives only strain names on pharmacy pages.
  • How fast the offering changes

    An example from 2025 shows the pace. On 24 June 2025 Aurora announced the launch in Poland of two products: Farm Gas (THC 27%, CBD <1%) from 30 June on prescription, and Sourdough (THC 29%, CBD <1%) from the beginning of August. According to the announcement, the products are grown and manufactured at Canadian facilities with GACP and EU-GMP certification.

    Today both products (Aurora THC 27% and 29%) are in our overview. It is a good illustration that the October 2026 overview will become outdated faster than it seems. That is why we record the verification date for each entry.

    Where the data comes from and how to read it

    The overview collects publicly available data from producers, distributors and pharmacies. For 136 of the 147 entries the verification source is a pharmacy page, for 10 the producer's material, for one a strain database. You will find the full list with links to sources in the product overview.

    It is not an official register and does not replace the leaflet of a specific package.

    Frequently asked questions

    Which producer is the best?

    We do not rate that. The text describes the market in numbers and does not recommend products; the choice is made by the doctor.

    Is this a complete list of everything in pharmacies?

    It is a list of entries that we managed to confirm in public sources on 19.10.2026. New products appear and disappear, so check current availability, which we write about in the article on why a product is sometimes out of stock at the pharmacy.

    Why do producers differ in the number of entries?

    From the way a producer records its offers: some have many strains under one formulation (S-LAB, Tilray), others one strain per formulation (Cantourage).

    Sources

  • Aurora: Aurora sets new standard in Poland with the launch of two high-potency flower products (24.06.2025)
  • GdziePoLek: Cannabis flos Aurora THC 29%, CBD<1%
  • Pharmacy pages (doz.pl, GdziePoLek), leaflets and producer websites listed next to each entry in the CannabisMedic product overview, as of 19.10.2026.
  • This text is informational: it collects publicly available data from producers, distributors and pharmacies. It does not describe effects or indications, is not an advertisement or a recommendation, and the choice of product and dosage is always decided by the doctor.

    Ready to start therapy?

    Book online in 60 seconds - consultation at our clinic in Krakow, Bydgoszcz, Toruń or Kielce.

    Book a consultation